The study will be carried out by the Center.
Gamaleya with the participation of volunteers aged 18 to 55 "to assess the tolerability, safety and immunogenicity of the medicinal product."
Formerly academician of the Russian Academy of Sciences, head of the Center.
Gamalei of the Ministry of Health of Russia Alexander Gintsburg said that in the center.
Gamaleyas are preparing for clinical trials of a coronavirus vaccine based on the Omicron and Delta strains.